Riskpilot← Back to searchSign inGet full accessMEDDEV Consulting AB
ABActiveOrg 5591712053Sjömilsgatan 9 Lgh 1102Engineering activities and related technical consultancy · NACE 7112Est. 20180 employees
Revenue 2025
SEK 0
EBITDA margin
—
+24% vs 2024
Equity ratio
94.8%
Financial strength
Net profit 2025
SEK 35K
+247% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -21K | +24% |
| Net profit | SEK 35K | +247% |
| Total assets | SEK 416K | +8% |
| Equity | SEK 395K | +10% |
| Employees | 0 | — |
Legal name
MEDDEV Consulting AB
Org number
5591712053
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
12 september 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva rådgivning och operativ service till framförallt medicintekniska bolag inom det regulatoriska området som berör globala medicintekniska registreringar, CE-märkning, tekniska filer, kvalitetsrevisioner, kvalitetssystem och processer samt därmed förenlig verksamhet.
Address
Sjömilsgatan 9 Lgh 1102
Email
ajrula@meddev.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 089 | 2 262 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | −0 |
| EBITDA | 752 | 413 | −79 | −28 | −21 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 752 | 413 | −79 | −28 | −21 |
| Net financials | −3 | −62 | 37 | 3 | 57 |
| Profit before tax | 750 | 382 | −41 | −24 | 35 |
| Tax | −157 | −86 | −0 | −0 | −0 |
| Net profit | 593 | 296 | −41 | −24 | 35 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 515 | 1 716 | 808 | 384 | 416 |
| Equity | 1 129 | 1 125 | 784 | 359 | 395 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 386 | 591 | 24 | 24 | 22 |
| Total debt | 386 | 591 | 24 | 24 | 22 |
EBITDA margin
-2125900.0%
This company
15.8%
Market median
-13455163% vs market
20212025
Equity ratio
94.8%
This company
38.2%
Market median
+148% vs market
20212025
Return on equity
8.9%
This company
18.4%
Market median
-52% vs market
20212025
Net profit margin
3526000.0%
This company
8.1%
Market median
+43530764% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RM | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDDEV Consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Martin von Brömsen | Audit | 0 companies |
| Ajrula Zuta | Board of Directors | 0 companies |
| Baskim Zuta | Deputy Board Member | 0 companies |